Koyfin Home > Directory > Health Care > Amicus Therapeutics > Net Income

Amicus Therapeutics Net Income Chart (FOLD)

Amicus Therapeutics annual/quarterly Net Income from 2006 to 2018. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Amicus Therapeutics Net Income for the quarter ending December 12, 2018 was $-78m a 36.07% decrease of -28m year over year
  • Amicus Therapeutics Net Income for the last 12 months ending December 12, 2018 was $-349m a 20.08% decrease of -70m year over year
  • Amicus Therapeutics Annual Net Income for 2018 was $-349m a 18.62% decrease of -65m from 2017
  • Amicus Therapeutics Annual Net Income for 2017 was $-284m a 29.56% decrease of -84m from 2016
  • Amicus Therapeutics Annual Net Income for 2016 was $-200m a 33.95% decrease of -68m from 2015
Other Income Statement Metrics:
  • Amicus Therapeutics EBITDA for the quarter ending December 12, 2018 was $-68m a 20.09% decrease of -14m year over year
  • Amicus Therapeutics Total Revenue for the quarter ending September 09, 2018 was $21m a 28.49% increase of 6m year over year
View Chart On Koyfin

Quarterly FOLD Net Income Data

12/2018$-78m
09/2018$-159m
06/2018$-62m
03/2018$-50m
12/2017$-69m
09/2017$-112m
06/2017$-48m
03/2017$-55m
12/2016$-59m
09/2016$-47m

Annual FOLD Net Income Data

2018$-349m
2017$-284m
2016$-200m
2015$-132m
2014$-69m
2013$-60m
2012$-49m
2011$-44m
2010$-55m
2009$-7m